U.S. Markets open in 1 hr 15 mins

Jazz Pharmaceuticals Public Limited Company (JAZZ)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
146.01-1.39 (-0.94%)
At close: 4:00PM EDT

141.00 -5.01 (-3.43%)
Pre-Market: 7:58AM EDT

People also watch
Full screen
Previous Close147.40
Bid95.82 x 100
Ask141.00 x 200
Day's Range145.85 - 148.35
52 Week Range95.80 - 163.75
Avg. Volume457,634
Market Cap8.77B
PE Ratio (TTM)22.06
EPS (TTM)6.62
Earnings DateNov 6, 2017 - Nov 10, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est184.63
Trade prices are not sourced from all markets
  • PR Newswire16 hours ago

    Jazz Pharmaceuticals Announces Offering of $500 Million of Exchangeable Senior Notes due 2024

    DUBLIN, Aug. 17, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced an offering by Jazz Investments I Limited, its wholly-owned subsidiary (the "Issuer"), of $500 million aggregate principal amount of exchangeable senior notes due 2024 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act").  The Issuer has also granted the initial purchasers a 13-day option to purchase up to an additional $75 million aggregate principal amount of notes. Jazz Pharmaceuticals plc intends to use the net proceeds from this offering to repay all or a substantial portion of $500 million of outstanding borrowings under its revolving credit facility.  Any remaining net proceeds will be used for general corporate purposes, including potential business development activities.

  • ACCESSWIRE3 days ago

    Earnings Review and Free Research Report: Illumina Reported Better Than Expected Revenue and Earnings Results

    Research Desk Line-up: Jazz Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 15, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Illumina, Inc. (NASDAQ: ILMN ), ...

  • Thomson Reuters StreetEvents3 days ago

    Edited Transcript of JAZZ earnings conference call or presentation 8-Aug-17 8:30pm GMT

    Q2 2017 Jazz Pharmaceuticals PLC Earnings Call